GlassScriptPhysician profile
Brian Francis Simpson
NPI 1316357544
$6,485.10
in general payments reported to CMS, 2019-2025
24 companies · $52.75 in 2025
The $52.75 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,028 · 2020: $1,757 · 2021: $743 · 2022: $1,001 · 2023: $731 · 2024: $173 · 2025: $52.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,668.80 | 2019-2023 | Dragonfly Opstar, Pressurewire |
| Medtronic, INC. | $1,376.34 | 2021-2025 | Linq II |
| Boston Scientific Corporation | $291.37 | 2022-2025 | Watchman Access System, Opticross, General - Therapies |
| Acist Medical Systems, INC. | $169.00 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.51 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $151.44 | 2020-2023 | Camzyos, Eliquis |
| Amgen INC. | $104.42 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $98.66 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $55.69 | 2023 | Optimizer |
| Amarin Pharma, INC. | $53.40 | 2020-2021 | |
| Edwards Lifesciences Corporation | $49.86 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $49.35 | 2019-2020 | |
| Abiomed | $32.45 | 2023 | Impella |
| Janssen Pharmaceuticals, INC | $27.88 | 2019-2022 | |
| United Therapeutics Corporation | $27.01 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $25.05 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $23.79 | 2019-2020 | |
| Pfizer INC. | $22.48 | 2021 | |
| Teleflex LLC | $20.28 | 2021 | |
| Shockwave Medical, INC | $18.25 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Vifor Pharma, INC. | $16.89 | 2019 | |
| Lundbeck LLC | $13.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.54 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.